AR088564A1 - PROCESO PARA LA PREPARACION DE AGONISTAS Y COMPUESTOS INTERMEDIOS DE b3 - Google Patents

PROCESO PARA LA PREPARACION DE AGONISTAS Y COMPUESTOS INTERMEDIOS DE b3

Info

Publication number
AR088564A1
AR088564A1 ARP120104036A ARP120104036A AR088564A1 AR 088564 A1 AR088564 A1 AR 088564A1 AR P120104036 A ARP120104036 A AR P120104036A AR P120104036 A ARP120104036 A AR P120104036A AR 088564 A1 AR088564 A1 AR 088564A1
Authority
AR
Argentina
Prior art keywords
compound
formula
produce
catalyst
reduction
Prior art date
Application number
ARP120104036A
Other languages
English (en)
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of AR088564A1 publication Critical patent/AR088564A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
  • Catalysts (AREA)

Abstract

Reivindicación 1: Un proceso para la preparación del compuesto de fórmula (1), que comprende: (a) reacción del compuesto de fórmula (2), con un reactivo protector de acetonida seleccionado entre el grupo que consiste en 2,2-dimetoxipropano, 2,2-dietoxipropano, 2-metoxipropeno y acetona, para producir el compuesto de fórmula (3); (b) reducción del compuesto de fórmula (3) con un agente reductor a una temperatura de 0ºC a 40ºC para producir el compuesto de fórmula (4); (c) oxidación del compuesto de fórmula (4) con un agente oxidante en presencia de un disolvente y de un catalizador para producir el compuesto de fórmula (5); (d) reacción del compuesto de fórmula (5) con un compuesto de fosfato de fórmula (6) para producir el compuesto de fórmula (7); (e) reducción del compuesto de fórmula (7) en presencia de un catalizador para producir el compuesto (8); (f) reacción del compuesto de fórmula (8) con un ácido para producir el compuesto de fórmula (9); (g) reducción del compuesto de fórmula (9) en presencia de un catalizador para producir el compuesto de fórmula (1); en el que cada uno de P¹ y P² se selecciona independientemente entre el grupo que consiste en Ac, Bn, Boc, Bz, Cbz, DMPM, FMOC, Ns, Moz, y Ts; y R¹ se selecciona entre el grupo que consiste en alquilo C₁₋₆, bencilo y fenilo.
ARP120104036A 2011-10-27 2012-10-26 PROCESO PARA LA PREPARACION DE AGONISTAS Y COMPUESTOS INTERMEDIOS DE b3 AR088564A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161552200P 2011-10-27 2011-10-27

Publications (1)

Publication Number Publication Date
AR088564A1 true AR088564A1 (es) 2014-06-18

Family

ID=48168357

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120104036A AR088564A1 (es) 2011-10-27 2012-10-26 PROCESO PARA LA PREPARACION DE AGONISTAS Y COMPUESTOS INTERMEDIOS DE b3

Country Status (7)

Country Link
US (4) US9809536B2 (es)
EP (1) EP2771006B1 (es)
JP (1) JP6088535B2 (es)
AR (1) AR088564A1 (es)
ES (1) ES2584427T3 (es)
TW (1) TW201323406A (es)
WO (1) WO2013062878A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6063948B2 (ja) * 2011-10-27 2017-01-18 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. ベータ3アゴニストおよび中間体を製造するプロセス
ES2584427T3 (es) 2011-10-27 2016-09-27 Merck Sharp & Dohme Corp. Proceso para la preparación de agonistas beta 3 y productos intermedios
JP6383403B2 (ja) 2013-03-15 2018-08-29 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. β−3作動薬および中間体の製造方法
EP4410295A3 (en) 2017-06-06 2024-10-16 Urovant Sciences GmbH Use of vibegron to treat overactive bladder
EP3634488A1 (en) 2017-06-06 2020-04-15 Urovant Sciences GmbH Dosing of vibegron for treatment of overactive bladder
WO2019224788A1 (en) 2018-05-23 2019-11-28 Urovant Sciences Gmbh Use of vibegron to treat pain associated with irritable bowel syndrome
SG11202103662VA (en) 2018-12-05 2021-06-29 Urovant Sciences Gmbh Vibegron for the treatment of overactive bladder symptoms
KR20260049872A (ko) 2019-03-18 2026-04-14 유로반트 사이언시즈 게엠베하 과민성 방광을 치료하기 위한 비베그론의 용도
JP7677630B2 (ja) 2019-05-01 2025-05-15 コデクシス, インコーポレイテッド 操作されたグルコースデヒドロゲナーゼ、ならびにケトンおよびアミン化合物の還元的アミノ化を行うための方法
US20220372542A1 (en) * 2019-10-02 2022-11-24 Abbott Diabetes Care Inc. Detection of analytes by protein switches
CN112708644B (zh) * 2019-10-25 2024-05-28 弈柯莱生物科技(集团)股份有限公司 氟苯尼考中间体的制备方法
CN112176007B (zh) * 2020-10-12 2022-07-22 上海医药工业研究院 一种氨基醇手性中间体的制备方法
JP2024501661A (ja) 2020-12-22 2024-01-15 ウロバント サイエンシズ ゲーエムベーハー 過活動膀胱を治療するためのビベグロンの使用と併用したジゴキシンのモニタリング方法
WO2022175848A1 (en) 2021-02-16 2022-08-25 Urovant Sciences Gmbh Methods of treating heart failure with vibegron
GB202113588D0 (en) * 2021-09-23 2021-11-10 Atrogi Ab New compounds and methods
CN113816917B (zh) * 2021-11-19 2022-02-18 奥锐特药业(天津)有限公司 一种维贝格龙中间体的制备方法
CN116004738A (zh) * 2022-10-09 2023-04-25 中国计量大学 一种酮还原酶在维贝格龙中间体生产中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525202B2 (en) 2000-07-17 2003-02-25 Wyeth Cyclic amine phenyl beta-3 adrenergic receptor agonists
DOP2003000587A (es) 2002-02-27 2003-08-30 Pfizer Prod Inc AGONISTAS DEL RECEPTOR ß3-ADRENERGICO
FR2874011B1 (fr) 2004-08-03 2007-06-15 Sanofi Synthelabo Derives de sulfonamides, leur preparation et leur application en therapeutique
CN101855342B (zh) * 2007-09-13 2013-07-10 科德克希思公司 用于还原苯乙酮的酮还原酶多肽
PE20091825A1 (es) 2008-04-04 2009-12-04 Merck & Co Inc Hidroximetil pirrolidinas como agonistas del receptor adrenergico beta 3
SG10201404330VA (en) 2008-08-29 2014-10-30 Codexis Inc Ketoreductase Polypeptides For The Stereoselective Production Of (4S)-3[(5S)-5(4-Fluorophenyl)-5-Hydroxypentanoyl]-4-Phenyl-1,3-Oxazolidin-2-One
IN2012DN02782A (es) 2009-10-07 2015-09-18 Merck Sharp & Dohme
AU2011245499B2 (en) 2010-04-30 2014-09-25 Merck Sharp & Dohme Corp. Novel beta 3 adrenergic receptor agonists
JP6063948B2 (ja) * 2011-10-27 2017-01-18 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. ベータ3アゴニストおよび中間体を製造するプロセス
ES2584427T3 (es) 2011-10-27 2016-09-27 Merck Sharp & Dohme Corp. Proceso para la preparación de agonistas beta 3 y productos intermedios
EP2780448B1 (en) 2011-11-18 2019-09-11 Codexis, Inc. Biocatalysts for the preparation of hydroxy substituted carbamates
JP6383403B2 (ja) 2013-03-15 2018-08-29 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. β−3作動薬および中間体の製造方法

Also Published As

Publication number Publication date
WO2013062878A1 (en) 2013-05-02
JP2015501319A (ja) 2015-01-15
US10577316B2 (en) 2020-03-03
US11767292B2 (en) 2023-09-26
US20140242645A1 (en) 2014-08-28
EP2771006B1 (en) 2016-05-25
US20200290962A1 (en) 2020-09-17
US9809536B2 (en) 2017-11-07
JP6088535B2 (ja) 2017-03-08
EP2771006A4 (en) 2015-04-15
TW201323406A (zh) 2013-06-16
US20180029981A1 (en) 2018-02-01
US11124478B2 (en) 2021-09-21
ES2584427T3 (es) 2016-09-27
EP2771006A1 (en) 2014-09-03
US20220073459A1 (en) 2022-03-10

Similar Documents

Publication Publication Date Title
HUE056900T2 (hu) Korszerû architektúrájú reaktor CO2, CO és más kémiai vegyületek elektrokémiai reakciójához
ECSP12012292A (es) Ciertas amino-piridazinas, composicioines de las mismas y métodos de uso de los mismos
PE20142456A1 (es) COMPUESTOS DE OXAZOLIDIN-2-ONA Y USOS DE LOS MISMOS COMO INHIBIDORES DE LA PI3Ks
EA201791873A1 (ru) Полиморф ингибиторов syk
NZ716598A (en) Anthelmintic compounds and compositions and method of using thereof
ES2684517T3 (es) Compuestos de heterociclilo como inhibidores de MEK
AR091519A1 (es) Inhibidores pirrolopirazona de tanquirasa
BR112014029551A2 (pt) compostos de ácido dimetil-benzoico
ES2626801T3 (es) Compuestos de triazolopiridina como inhibidores de pde10a
JO3063B1 (ar) مركب مبتكر وطرق لانتاجه
CU24366B1 (es) Compuestos que poseen un anillo que contiene nitrógeno salicílico unido a un grupo heteroarilo bicíclico útiles como inhibidores rorc2
PE20150182A1 (es) Compuestos de fenoxietil piperidina
ES2721659T3 (es) Aparato para generar 1-metilciclopropeno
EA201590770A1 (ru) Ингибиторы вируса гепатита с
PE20140917A1 (es) Sintesis de derivados de 2-carboxamida-cicloamino-urea
EP2936998A4 (en) TTEOK COMPOSITION WITH TAGATOSE, TTEOK AND MANUFACTURING METHOD THEREFOR
MX2019008652A (es) Metodos mejorados para la acilacion del maitansinol.
AR088358A1 (es) Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos
AR101136A1 (es) Proceso para la preparación de ácidos 3-hidroxipicolínicos
BR112015006370A2 (pt) meios e métodos para tratamento de tumores sólidos
AR081732A1 (es) Composicion de control de fitoenfermedades y metodo para controlar fitoenfermedades
AR087345A1 (es) Metodos para la preparacion de compuestos de tiofeno
AR077332A1 (es) Procesos para la alquilacion de pirazoles
AR081804A1 (es) Composicion de control de fitoenfermedades y metodo para controlar fitoenfermedades
CO6700822A2 (es) Proceso para preparar 3-haloalquilporazoles

Legal Events

Date Code Title Description
FG Grant, registration